Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

542 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Approaches towards the development of chimeric DPP4/ACE inhibitors for treating metabolic syndrome.
Sattigeri JA, Sethi S, Davis JA, Ahmed S, Rayasam GV, Jadhav BG, Chilla SM, Datta D, Gadhave A, Tulasi VK, Jain T, Voleti S, Benjamin B, Udupa S, Jain G, Singh Y, Srinivas K, Bansal VS, Ray A, Bhatnagar PK, Cliffe IA. Sattigeri JA, et al. Among authors: jain t, jain g. Bioorg Med Chem Lett. 2017 Jun 1;27(11):2313-2318. doi: 10.1016/j.bmcl.2017.04.036. Epub 2017 Apr 13. Bioorg Med Chem Lett. 2017. PMID: 28442252
Synthesis and evaluation of thiomannosides, potent and orally active FimH inhibitors.
Sattigeri JA, Garg M, Bhateja P, Soni A, Rauf ARA, Gupta M, Deshmukh MS, Jain T, Alekar N, Barman TK, Jha P, Chaira T, Bambal RB, Upadhyay DJ, Nishi T. Sattigeri JA, et al. Among authors: jain t. Bioorg Med Chem Lett. 2018 Sep 15;28(17):2993-2997. doi: 10.1016/j.bmcl.2018.06.017. Epub 2018 Jun 12. Bioorg Med Chem Lett. 2018. PMID: 30017316
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts.
Choi IY, Ling JP, Zhang J, Helmenstine E, Walter W, Tsakiroglou P, Bergman RE, Philippe C, Manley JL, Rouault-Pierre K, Li B, Wiseman DH, Batta K, Ouseph MM, Bernard E, Dubner B, Li X, Haferlach T, Koget A, Fazal S, Jain T, Gocke CD, DeZern AE, Dalton WB. Choi IY, et al. Among authors: jain t. Blood Adv. 2024 May 17:bloodadvances.2023011260. doi: 10.1182/bloodadvances.2023011260. Online ahead of print. Blood Adv. 2024. PMID: 38759096
Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis.
Wang TP, Ahn KW, Shadman M, Kaur M, Ahmed N, Bacher U, Cerny J, Chen A, Epperla N, Frigault M, Grover N, Haverkos B, Hill B, Hossain N, Iqbal M, Jain T, Krem MM, Maakaron J, Modi D, Alhaj Moustafa M, Riedell P, Savani B, Sica RA, Sureda A, Wudhikarn K, Herrera AF, Sauter C, Hamadani M, Jimenez Jimenez A. Wang TP, et al. Among authors: jain t. Leukemia. 2024 May 15. doi: 10.1038/s41375-024-02242-6. Online ahead of print. Leukemia. 2024. PMID: 38750138
ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell Therapy.
Hashmi H, Kumar A, Kharfan-Dabaja MA, Munshi PN, Inamoto Y, DeFilipp Z, Dholaria B, Jain T, Perales MA, Carpenter PA, Hamadani M, Dhakal B, Usmani SZ. Hashmi H, et al. Among authors: jain t. Transplant Cell Ther. 2024 Apr 12:S2666-6367(24)00347-6. doi: 10.1016/j.jtct.2024.04.007. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38615990 Free article.
Picture Perfect Predictive Model: Does it Exist?
Sainatham C, Jain T. Sainatham C, et al. Among authors: jain t. Transplant Cell Ther. 2024 Apr;30(4):344-346. doi: 10.1016/j.jtct.2024.03.013. Transplant Cell Ther. 2024. PMID: 38604717 No abstract available.
542 results